Asia-Pacific biopharma conferences in early 2025 are forging strategic partnerships, launching research initiatives, and accelerating drug development.
Asia-Pacific biopharma conferences in early 2025 are forging strategic partnerships, launching research initiatives, and accelerating drug development.
Innovation, investment, and ideals intersected dramatically at the AI Action Summit—held 10–11 February at Paris’s Grand Palais. Co-chaired …
The 26th Clinical Trial Supply Europe conference (25–26 February, Barcelona) will showcase how AI, logistics innovation, and regulatory …
A new survey finds that over 80% of healthcare professionals notice sex-related differences in disease progression and treatment …
Multiple clinical-stage biotechs unveil bold 2025 roadmaps—from Denali’s upcoming BLA for Hunter syndrome to Cabaletta’s expanding autoimmune cell …
Bio‑Path outlines a robust development and regulatory path ahead, aiming to advance both cancer and obesity-focused therapies using …
The 43rd annual J.P. Morgan Healthcare Conference begins in San Francisco under tighter security and market uncertainty, but …
Already a subscriber? Log in